Gennady Gekht
Interventional Pain Medicine · Lakewood Ranch, FLNPI 1932146842
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $16,000 of the $20,629 with a category attached, or 77.6%. Stryker accounts for 83.0% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2019 at $12,541 and has fallen 98.7% since, to $159 in 2024.
Across 173 payments — averaging $119.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$17K
- Nevro Corp.$763
- AbbVie$626
- Abbott$402
- Curonix LLC$315
- Amgen$213
- plus $1K from 18 others
Across 12 payments — averaging $491.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$6K
- Medtronic$250
What the payments were for
- Consulting fees$16,00078%
- Travel & lodging$1,2066%
- Food & beverage$3,42317%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 17 | $17,133 |
| Nevro Corp. | 26 | $763 |
| AbbVie(2 entities) | 36 | $626 |
| Abbott | 8 | $402 |
| Curonix LLC | 4 | $315 |
| Amgen(2 entities) | 18 | $213 |
| Vertos Medical, Inc. | 4 | $207 |
| Vertiflex, Inc. | 11 | $193 |
| Novartis | 13 | $146 |
| Pfizer | 6 | $112 |
| Teva Pharmaceuticals USA, Inc. | 6 | $94 |
| Boston Scientific | 4 | $81 |
| Scilex Pharmaceuticals Inc. | 3 | $66 |
| IBSA Pharma Inc. | 3 | $56 |
| Lilly USA, LLC | 4 | $55 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $37 |
| Impel Pharmaceuticals Inc. | 1 | $22 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $19 |
| Painteq LLC | 1 | $18 |
| Nalu Medical, Inc. | 1 | $17 |
| Pacira Pharmaceuticals Incorporated | 1 | $13 |
| Pacira Therapeutics, Inc. | 1 | $13 |
| Medtronic | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IVS - VERTEBRAL AUGMENTATION PRODUCTS$7,999
- IVS - NEEDLES - OTHER$5,797
- IVS - MULTIGEN RF$5,797
- IVS - MULTIGEN 2RF$2,766
- SPINEJACK$2,750
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$273
- IVS - RF CANNULAE/NEEDLES$266
- Proclaim Family of SCS IPGs$240
- mild Device Kit$162
- Senza$139
- Omnia$120
- Superion ISS$109
How this compares
$20,629 in reported general payments places this provider in the 85th percentile of 278 interventional pain medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Baclofen | 13 | $129 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Lakewood Ranch
- Louis RasoJupiter$1.3M
- Ajay AntonyGainesville$1.1M
- Michael EspositoVero Beach$777K
- Nomen AzeemRiverview$650K
- Stanley GolovacMerritt Island$367K
- Sunil PanchalLutz$363K
- Robert BallPort Charlotte$246K
- Justin MannJacksonville$243K
- Giuseppe PaeseBoca Raton$180K
- Miguel de la GarzaNew Port Richey$138K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.